{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:20:30Z","timestamp":1790619630165,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108657","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:10:07Z","timestamp":1756480207000},"page":"108657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Molecular docking and dynamics simulations of 4-heteroarylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives as potential anticancer agents"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6681-0251","authenticated-orcid":false,"given":"Jose","family":"Siguenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-0836","authenticated-orcid":false,"given":"Haci","family":"Baykara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May","key":"10.1016\/j.compbiolchem.2025.108657_bib1","article-title":"Exploring schiff base ligand inhibitor for cancer and neurological cells, viruses and bacteria receptors by homology modeling and molecular docking","volume":"23","author":"Abdeldjebar","year":"2022","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.141176","article-title":"Anti-breast cancer potential of new indole derivatives: synthesis, in-silico study, and cytotoxicity evaluation on MCF-7 cells","volume":"1326","author":"Abood","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108657_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200188","article-title":"Speed vs accuracy: effect on ligand pose accuracy of varying box size and exhaustiveness in AutoDock vina","volume":"42","author":"Agarwal","year":"2023","journal-title":"Mol. Inf."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib4","article-title":"1,2,3-Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch. Pharm. (Weinh. )"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2024.101897","article-title":"Molecular modeling and cytotoxic activity of newly synthesized benzothiazole-thiazole conjugates","volume":"28","author":"Alamoudi","year":"2024","journal-title":"J. Saudi Chem. Soc."},{"issue":"19","key":"10.1016\/j.compbiolchem.2025.108657_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910324","article-title":"Halting tumor progression via novel Non-Hydroxamate Triazole-Based mannich bases MMP-2\/9 inhibitors; design, Microwave-Assisted synthesis, and biological evaluation","volume":"22","author":"Albelwi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.compbiolchem.2025.108657_bib7","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.3390\/ijms242316716","article-title":"Synthesis and characterization of a new class of Chromene-Azo sulfonamide hybrids as promising anticancer candidates with the exploration of their EGFR, hCAII, and MMP-2 inhibitors based on molecular docking assays","volume":"24","author":"Alblewi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s44371-024-00071-1","article-title":"Exploration of marine natural compounds as promising MDM2 inhibitors for treating triple-negative breast cancer: insights from molecular docking, ADME\/T studies, molecular dynamics simulation and MM-PBSA binding free energy calculations","volume":"1","author":"Ali","year":"2024","journal-title":"Discov. Chem."},{"issue":"38","key":"10.1016\/j.compbiolchem.2025.108657_bib9","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108657_bib10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1107\/S0907444913004459","article-title":"The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant","volume":"69","author":"Anil","year":"2013","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib11","unstructured":"ANON \u201cFree Chemical Drawing Software for Students | ChemSketch | ACD\/Labs.\u201d \u3008https:\/\/www.acdlabs.com\/resources\/free-chemistry-software-apps\/chemsketch-freeware\/\u3009 (accessed Apr. 14, 2025)."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib12","unstructured":"ANON \u201cRCSB PDB - 4EKU: Crystal Structure of FERM Domain of Proline-rich Tyrosine Kinase 2.\u201d \u3008https:\/\/www.rcsb.org\/structure\/4EKU\u3009 (accessed Apr. 24, 2025)."},{"issue":"7795","key":"10.1016\/j.compbiolchem.2025.108657_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41586-020-2000-y","article-title":"NEDD8 nucleates a multivalent cullin\u2013RING\u2013UBE2D ubiquitin ligation assembly","volume":"578","author":"Baek","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/ml500353p","article-title":"Structure-based drug design of novel potent and selective tetrahydropyrazolo[1,5-a]pyrazines as ATR inhibitors","volume":"6","author":"Barsanti","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140393","article-title":"Synthesis, molecular docking, drug likeness, in silico toxicity and DFT studies of small molecules as p53-MDM2 interaction and COX-2 dual inhibitors","volume":"1322","author":"Basha","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108657_bib16","doi-asserted-by":"crossref","first-page":"20210027","DOI":"10.1515\/jib-2021-0027","article-title":"In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors\/AA2AR antagonists for the treatment of Parkinson\u2019s disease","volume":"19","author":"Boulaamane","year":"2022","journal-title":"J. Integr. Bioinform"},{"issue":"D1","key":"10.1016\/j.compbiolchem.2025.108657_bib17","doi-asserted-by":"crossref","first-page":"D464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB protein data bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology, and energy","volume":"47","author":"Burley","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib18","article-title":"Discovery of pyridine-based derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia","volume":"283","author":"Chen","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108657_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189169","article-title":"Cullin-RING ligase 4 in cancer: structure, functions, and mechanisms","volume":"1879","author":"Cheng","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib20","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1021\/acs.jcim.3c01853","article-title":"Unlocking precision docking for metalloproteins","volume":"64","author":"Clemente","year":"2024","journal-title":"J. Chem. Inf. Model"},{"issue":"11","key":"10.1016\/j.compbiolchem.2025.108657_bib21","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1073\/pnas.0809645106","article-title":"Crystal structure of human CDK4 in complex with a D-type cyclin","volume":"106","author":"Day","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108657_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061392","article-title":"Carbonic anhydrase IX: a renewed target for cancer immunotherapy","volume":"14","author":"de Campos","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s10020-024-00921-9","article-title":"Targeting PYK2, entrectinib allays anterior subcapsular cataracts in mice by regulating TGF\u03b22 signaling pathway","volume":"30","author":"Ding","year":"2024","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib24","doi-asserted-by":"crossref","first-page":"2400423","DOI":"10.1080\/15592294.2024.2400423","article-title":"Exploring fatty acids from royal jelly as a source of histone deacetylase inhibitors: from the hive to applications in human well-being and health","volume":"19","author":"dos Santos France","year":"2024","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-022-00879-x","article-title":"Synthesis, biological evaluation and molecular docking of new triphenylamine-linked pyridine, thiazole and pyrazole analogues as anticancer agents","volume":"16","author":"Elmorsy","year":"2022","journal-title":"BMC Chem."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13065-022-00887-x","article-title":"Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents,","volume":"16","author":"Emami","year":"2022","journal-title":"BMC Chem."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib27","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.4c05804","article-title":"Novel Dibenzoazepine-Substituted triazole hybrids as cholinesterase and carbonic anhydrase inhibitors and anticancer agents: synthesis, characterization, biological evaluation, and in silico studies","author":"Erdo\u011fan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11030-023-10603-z","article-title":"New antiproliferative 3-substituted oxindoles inhibiting EGFR\/VEGFR-2 and tubulin polymerization","volume":"28","author":"Ezelarab","year":"2024","journal-title":"Mol. Divers"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib29","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108657_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051184","article-title":"Review of therapeutic strategies for anaplastic lymphoma Kinase-Rearranged Non-Small cell lung cancer","volume":"14","author":"Fukui","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"270","key":"10.1016\/j.compbiolchem.2025.108657_bib31","article-title":"NF-\u03baB signaling in therapy resistance of breast cancer: mechanisms, approaches, and challenges","volume":"348","author":"Guo","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108657_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2014.07.015","article-title":"Drugging MYCN through an allosteric transition in aurora kinase a","volume":"26","author":"Gustafson","year":"2014","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108657_bib33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"July","key":"10.1016\/j.compbiolchem.2025.108657_bib34","article-title":"Unraveling the ncRNA landscape that governs colorectal cancer: a roadmap to personalized therapeutics","volume":"354","author":"Hamdy","year":"2024","journal-title":"Life Sci."},{"issue":"15","key":"10.1016\/j.compbiolchem.2025.108657_bib35","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1021\/jm800566m","article-title":"Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2- pyrimidinyl]amino]-2-methyl-benzenesulfonamide (pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor","volume":"51","author":"Harris","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/i6060219","article-title":"Synthesis and GIAO NMR calculations for some novel 4-Heteroarylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives: comparison of theoretical and experimental 1H- and 13C- chemical shifts","volume":"6","author":"Haydar Y\u00fcksek Ismail Cakmak","year":"2005","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140081","article-title":"Synthesis, structural, DFT studies, biological effectiveness, and molecular docking aspects of multitarget novel N-(4-Phenylthiazol-2-yl)hydrazine carboxamide hybrids as COX inhibitors, Anti-TB, and Anti-oxidant activity","volume":"1321","author":"Hiremath","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108657_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.chembiol.2016.06.006","article-title":"Structural basis for KDM5A histone lysine demethylase inhibition by diverse compounds","volume":"23","author":"Horton","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib39","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3390\/ijms11083016","article-title":"Advances and challenges in Protein-Ligand docking","volume":"11","author":"Huang","year":"2010","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108657_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. \\ Eng."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib41","article-title":"Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach","volume":"9","author":"Ibrahim","year":"2020","journal-title":"Sci. Afr."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Inmaculada Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"5905","key":"10.1016\/j.compbiolchem.2025.108657_bib43","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1164772","article-title":"The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist","volume":"322","author":"Jaakola","year":"2008","journal-title":"Science (80. )"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib44","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1038\/s41598-023-35192-7","article-title":"Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-simulation, electrostatic potential energy simulation and ligand efficiency metrics","volume":"13","author":"Jain","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2015.08.010","article-title":"Structural insights into the benzophenanthridines binding to human glycine transporter GlyT1","volume":"765","author":"Jurksy","year":"2015","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108657_bib46","first-page":"1","article-title":"Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: a new group of RAF inhibitors for cancer treatment","volume":"13","author":"Kaboli","year":"2018","journal-title":"PLoS One"},{"issue":"7382","key":"10.1016\/j.compbiolchem.2025.108657_bib47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature10737","article-title":"X-ray structures of LeuT in substrate-free outward-open and apo inward-open states","volume":"481","author":"Krishnamurthy","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s13596-022-00640-8","article-title":"In silico ADMET, molecular docking and molecular simulation-based study of glabridin\u2019s natural and semisynthetic derivatives as potential tyrosinase inhibitors","volume":"23","author":"Kumari","year":"2023","journal-title":"Adv. Tradit. Med."},{"issue":"6610","key":"10.1016\/j.compbiolchem.2025.108657_bib49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyciooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.compbiolchem.2025.108657_bib50","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1002\/anie.201704616","article-title":"Structure of human tyrosinase related protein 1 reveals a binuclear zinc active site important for melanogenesis","volume":"56","author":"Lai","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108657_bib51","first-page":"242","article-title":"Molecular modeling and identification of flax microgreens lignans as novel prostate cancer target inhibitors","volume":"13","author":"Lawal","year":"2025","journal-title":"J. Appl. Biol. Biotechnol."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108657_bib52","first-page":"771","article-title":"Oleanolic acids inhibit vascular endothelial growth factor receptor 2 signaling in endothelial cells: implication for Anti-Angiogenic therapy","volume":"41","author":"Lee","year":"2018","journal-title":"Mol. Cells"},{"issue":"22","key":"10.1016\/j.compbiolchem.2025.108657_bib53","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of Cancer-Associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"issue":"December 2021","key":"10.1016\/j.compbiolchem.2025.108657_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","article-title":"EGFR signaling pathway as therapeutic target in human cancers","volume":"85","author":"Levantini","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108657_bib55","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/acs.biochem.5b01378","article-title":"Crystal structure of Aspirin-Acetylated human Cyclooxygenase-2: insight into the formation of products with reversed stereochemistry","volume":"55","author":"Lucido","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib56","doi-asserted-by":"crossref","unstructured":"M. Hrimla et al., \u201cClick Synthesis, Anticancer Activity, and Molecular Docking Investigation of some Functional 1,2,3-triazole Derivatives,\u201d 2021, doi: 10.33263\/BRIAC126.76337667.","DOI":"10.33263\/BRIAC126.76337667"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib57","doi-asserted-by":"crossref","unstructured":"M.J. Nelson and A.K. Hoover, \u201cNotes on Using Google Colaboratory in AI Education,\u201d in Annual Conference on Innovation and Technology in Computer Science Education, ITiCSE, 2020, pp. 533\u2013534.","DOI":"10.1145\/3341525.3393997"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128249","article-title":"Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: design, synthesis, computational and enzyme inhibition studies","volume":"48","author":"Manzoor","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib59","doi-asserted-by":"crossref","first-page":"105095","DOI":"10.1016\/j.bioorg.2021.105095","article-title":"Design, synthesis and in vitro biological evaluation of a novel class of anti-adenovirus agents based on 3-amino-1,2-propanediol","volume":"114","author":"Mazzotta","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108657_bib60","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","article-title":"MDTraj: a modern open library for the analysis of molecular dynamics trajectories","volume":"109","author":"McGibbon","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107581","article-title":"Prediction of the potential biological activity of novel spiropyrazolo[3,4-b]pyridines and spiropyrazolo[3,4-b]pyridine-5,5\u2032-pyrimidines by a ligand\u2013protein inverse-docking approach","volume":"97","author":"Mej\u00eda-Guti\u00e9rrez","year":"2020","journal-title":"J. Mol. Graph. Model"},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108657_bib62","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.bmcl.2005.03.034","article-title":"Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors","volume":"15","author":"Miyazaki","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib63","first-page":"115","article-title":"Open force field consortium: escaping atom types using direct chemical perception with SMIRNOFF formats","volume":"19","author":"Mobley","year":"2023","journal-title":"J. Chem. Theory Comput."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108657_bib64","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.toxlet.2013.08.010","article-title":"Computer-aided identification of novel protein targets of bisphenol a","volume":"222","author":"Montes-Grajales","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib65","doi-asserted-by":"crossref","first-page":"2423174","DOI":"10.1080\/14756366.2024.2423174","article-title":"Structure optimization and molecular dynamics studies of new tumor-selective s-triazines targeting DNA and MMP-10\/13 for halting colorectal and secondary liver cancers","volume":"39","author":"Morcos","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"October","key":"10.1016\/j.compbiolchem.2025.108657_bib66","article-title":"Integration of network pharmacology, metabolomics and lipidomics for clarifying the role of sphingolipid metabolism in the treatment of liver cancer by regorafenib","volume":"358","author":"Mu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib67","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11030-022-10437-1","article-title":"Evaluation of tea (Camellia sinensis L.) phytochemicals as multi-disease modulators, a multidimensional in silico strategy with the combinations of network pharmacology, pharmacophore analysis, statistics and molecular docking","volume":"27","author":"Nag","year":"2023","journal-title":"Mol. Divers"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib68","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1107\/S2053230X15005695","article-title":"Multiple crystal forms of N,N\u2032-diacetylchitobiose deacetylase from pyrococcus furiosus","volume":"71","author":"Nakamura","year":"2015","journal-title":"Acta Crystallogr. Sect. F. Struct. Biol. Commun."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Chemin.."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108657_bib70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0092-8674(02)00963-7","article-title":"Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains","volume":"110","author":"Ogiso","year":"2002","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108657_bib71","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.chemosphere.2010.06.020","article-title":"Theoretical targets for TCDD: a bioinformatics approach","volume":"80","author":"Olivero-Verbel","year":"2010","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib72","article-title":"Integrated approach for studying anti-angiotensin converting enzyme activity of triazole derivatives to down-regulate diabetes","volume":"23","author":"Oyebamiji Abel","year":"2024","journal-title":"J. Phytomedicine Ther."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib73","doi-asserted-by":"crossref","unstructured":"P. Eastman et al., \u201cOpenMM 7: Rapid development of high-performance algorithms for molecular dynamics,\u201d pp. 1\u201317, 2017.","DOI":"10.1101\/091801"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136021","article-title":"Designing strategies, structural activity relationships, and biological activity of recently developed nitrogen-containing heterocyclic compounds as epidermal growth factor receptor inhibitors","author":"Pal","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"March","key":"10.1016\/j.compbiolchem.2025.108657_bib75","article-title":"Computational and biological approaches in repurposing ribavirin for lung cancer treatment: unveiling antitumorigenic strategies","volume":"352","author":"Paudel","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-024-00507-5","article-title":"Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives","volume":"13","author":"Pu","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.53388\/MDM202407003","article-title":"Exploring the bioactive compounds of feiduqing formula for the prevention and management of COVID-19 through network pharmacology and molecular docking","volume":"7","author":"Qin","year":"2024","journal-title":"Med. Data Min."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib78","series-title":"Deep learning for the life sciences","author":"Ramsundar","year":"2019"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib79","article-title":"Exploring natural compounds as potential CDK4 inhibitors for therapeutic intervention in neurodegenerative diseases through computational analysis","author":"Rani","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105816","article-title":"Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation","volume":"124","author":"Reda Aouad","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108657_bib81","first-page":"597","article-title":"NGL viewer: a web application for molecular visualization","volume":"12","author":"Rose","year":"2015","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-2836(02)00262-0","article-title":"Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor","volume":"319","author":"Rowsell","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"17","key":"10.1016\/j.compbiolchem.2025.108657_bib83","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1039\/c2cc15625c","article-title":"Protein crystal structures with ferrocene and ruthenocene-based enzyme inhibitors","volume":"48","author":"Salmon","year":"2012","journal-title":"Chem. Commun."},{"issue":"13","key":"10.1016\/j.compbiolchem.2025.108657_bib84","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/acs.jmedchem.6b00653","article-title":"Controlling the dissociation of ligands from the adenosine A2A receptor through modulation of salt bridge strength","volume":"59","author":"Segala","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/biom15010035","article-title":"Targeting invasion: the role of MMP-2 and MMP-9 inhibition in colorectal cancer therapy","volume":"15","author":"Shoari","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138223","article-title":"Synthesis, biological evaluation and molecular docking studies of new pyrimidine derivatives as potent dual EGFR\/HDAC inhibitors","volume":"1309","author":"Sivaiah","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"48","key":"10.1016\/j.compbiolchem.2025.108657_bib87","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib88","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.3390\/ma14226916","article-title":"Synthesis, crystal structure, and biological evaluation of novel 5-Hydroxymethylpyrimidines","volume":"14","author":"Stolarczyk","year":"2021","journal-title":"Mater. (Basel)"},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108657_bib89","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib90","unstructured":"T. Fu, W. Gao, C.W. Coley, and J. Sun, \u201cReinforced Genetic Algorithm for Structure-based Drug Design,\u201d 2022, [Online]. Available: \u3008https:\/\/github.com\/futianfan\/reinforced-genetic-algorithm\u3009."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108657_bib91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nsmb.2924","article-title":"Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation","volume":"22","author":"Thevakumaran","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7013","key":"10.1016\/j.compbiolchem.2025.108657_bib92","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature02993","article-title":"Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase","volume":"432","author":"Thoma","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108657_bib93","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108657_bib94","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","article-title":"Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity","volume":"105","author":"Tsai","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib95","article-title":"Computational analysis of variant in tyrosinase protein using molecular dynamic simulation: an in silico approach","volume":"11","author":"Usmani","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib96","series-title":"Python reference manual","author":"Van Rossum","year":"1995"},{"issue":"5659","key":"10.1016\/j.compbiolchem.2025.108657_bib97","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by Small-Molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science (80. )"},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108657_bib98","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.5958\/0974-360X.2020.00493.X","article-title":"Molecular docking analysis of triazole analogues as inhibitors of human neutrophil elastase (HNE), matrix metalloproteinase (MMP 2 and MMP 9) and tyrosinase","volume":"13","author":"Vijayakumar","year":"2020","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103334","article-title":"PI3K inhibition in breast cancer: identifying and overcoming different flavors of resistance","volume":"162","author":"Vitale","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib100","article-title":"openforcefield\/openff-toolkit: 0.16.5 minor feature and bugfix release Pre-release","author":"Wagner","year":"2024","journal-title":"Zenodo"},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108657_bib101","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108657_bib102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cac2.12274","article-title":"The Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells","volume":"42","author":"Wang","year":"2022","journal-title":"Cancer Commun. (London England)"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib103","doi-asserted-by":"crossref","DOI":"10.1063\/1.5025118","article-title":"Affinity, kinetics, and pathways of anisotropic ligands binding to hydrophobic model pockets","author":"Wei\u00df","year":"2018","journal-title":"The Journal of Chemical Physics, 149(9)"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib104","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.freeradbiomed.2021.07.019","article-title":"Glycyrrhetinic acid induces oxidative\/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells","volume":"173","author":"Wen","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/v16060923","article-title":"Identification and analysis of biomarkers associated with lipophagy and therapeutic agents for COVID-19","volume":"16","author":"Wu","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib106","doi-asserted-by":"crossref","first-page":"1197418","DOI":"10.3389\/fphar.2023.1197418","article-title":"G. Lucidum triterpenes restores intestinal flora balance in non-hepatitis b virus-related hepatocellular carcinoma: evidence of 16S rRNA sequencing and network pharmacology analysis","volume":"14","author":"Xiong","year":"2023","journal-title":"Front. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108657_bib108","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/08927022.2022.2068799","article-title":"Structure-Based virtual screening, molecular docking, molecular dynamics simulation and pharmacokinetic modelling of Cyclooxygenase-2 (COX-2) inhibitor for the clinical treatment of colorectal cancer","volume":"48","author":"Yadav","year":"2022","journal-title":"Mol. Simul."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137425","article-title":"Based on virtual screening methods and biological activity assessment, AK-968\/13030056 has been identified as a potential mTOR inhibitor","volume":"1302","author":"Yang","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib110","article-title":"Exploring shared mechanisms between ulcerative colitis and psoriasis and predicting therapeutic natural compounds through bioinformatics and molecular docking","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108657_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.826","article-title":"Role of adenosine A2a receptor in cancers and autoimmune diseases","volume":"11","author":"Ye","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112271","article-title":"Protective effect of sargahydroquinoic acid against A\u03b225\u201335-evoked damage via PI3K\/Akt mediated Nrf2 antioxidant defense system","volume":"144","author":"Yoon","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib113","article-title":"Synthesis of new 1,2,4-triazole derivatives and investigation of their matrix metalloproteinase-9 (MMP-9) inhibition properties","author":"Yurtta\u015f","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.compbiolchem.2025.108657_bib114","doi-asserted-by":"crossref","DOI":"10.1140\/epjb\/s10051-024-00822-0","article-title":"Anthracenyl chalcone: a promising anticancer agent\u2014structural and molecular docking studies","volume":"97","author":"Zainuri","year":"2024","journal-title":"Eur. Phys. J. B"},{"key":"10.1016\/j.compbiolchem.2025.108657_bib115","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2592962","article-title":"Prognostic and immunological roles of MMP-9 in Pan-Cancer","volume":"2022","author":"Zeng","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108657_bib116","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/ct200100e","article-title":"A combined metadynamics and umbrella sampling method for the calculation of ion permeation free energy profiles","volume":"7","author":"Zhang","year":"2011","journal-title":"J. Chem. Theory Comput."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108657_bib117","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/ml400378e","article-title":"Crystal structures of PI3K\u03b1 complexed with PI103 and its derivatives: new directions for inhibitors design","volume":"5","author":"Zhao","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108657_bib118","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.chemrev.7b00305","article-title":"Electrostatic interactions in protein structure, folding, binding, and condensation","volume":"118","author":"Zhou","year":"2018","journal-title":"Chem. Rev."},{"issue":"7276","key":"10.1016\/j.compbiolchem.2025.108657_bib119","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nature08622","article-title":"Novel mutant-selective EGFR kinase inhibitors against EGFR T790M","volume":"462","author":"Zhou","year":"2009","journal-title":"Nature"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T22:14:24Z","timestamp":1765923264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125003184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":119,"alternative-id":["S1476927125003184"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108657","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular docking and dynamics simulations of 4-heteroarylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives as potential anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108657"}}